CRUK HUNTER Accelerator – delivering immunotherapy for liver cancer

Not Applicable

Suspended

• Conditions: iver cancer; Cancer; Malignant neoplasm of liver and intrahepatic bile ducts

• Registration Number: ISRCTN16680540
• Lead Sponsor: The Newcastle Upon Tyne Hospitals NHS Foundation Trust

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-12-10
• Last Update Posted: 8 January 2024
• Study Completion: 2025-11-30

Recruitment & Eligibility

• Status: Suspended
• Sex: All
• Target Recruitment: 1500

Inclusion Criteria

1. Patients will be over 18 years of age
2. The recruited patients will have primary liver cancer, secondary liver cancer or chronic liver disease
3. Patients will be attending the Newcastle upon Tyne NHS Foundation Trust, or one of the collaborating centres, for consideration of liver related treatment
4. The patient will be willing and able to provide written informed consent to take part in the study

Exclusion Criteria

1. Patients who have received previous treatment for HCC, unless recruited just prior to starting 2nd line treatment
2. Patients deemed too distressed or unwell to approach about taking part in the research project
3. Patients who lack capacity to give informed consent
4. Patients who are not able to undertake study procedures

Study & Design

• Study Type: Observational
• Study Design: Not specified